Private Capital Group’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-913
Closed -$168K 2243
2021
Q2
$168K Sell
913
-130
-12% -$22.3K 0.04% 262
2021
Q1
$159K Sell
1,043
-1,122
-52% -$174K 0.04% 258
2020
Q4
$338K Sell
2,165
-1,109
-34% -$143K 0.06% 213
2020
Q3
$375K Sell
3,274
-267
-8% -$28.8K 0.08% 171
2020
Q2
$397K Buy
3,541
+306
+9% +$32.5K 0.09% 163
2020
Q1
$290K Buy
3,235
+827
+34% +$81.2K 0.08% 183
2019
Q4
$260K Buy
2,408
+460
+24% +$49.2K 0.06% 216
2019
Q3
$191K Sell
1,948
-476
-20% -$53.7K 0.03% 305
2019
Q2
$301K Buy
2,424
+12
+0.5% +$1.55K 0.07% 171
2019
Q1
$326K Hold
2,412
0.06% 187
2018
Q4
$235K Sell
2,412
-26
-1% -$3.07K 0.05% 211
2018
Q3
$338K Buy
2,438
+14
+0.6% +$1.76K 0.07% 180
2018
Q2
$300K Sell
2,424
-12
-0.5% -$1.4K 0.06% 182
2018
Q1
$272K Sell
2,436
-458
-16% -$54.7K 0.06% 198
2017
Q4
$346 Buy
+2,894
New +$352K 0.08% 160

Other funds holding ALXN